FDA Inspection 1272386 — Petr Budera, M.D., Ph.D.
The FDA completed an inspection of Petr Budera, M.D., Ph.D. on May 23, 2025 in Central Boian Region. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 23, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Central Boian Region (Czech Republic)
Additional Details
Clinical BA/BE